The global cell culture vessels market size was valued at USD 4.90 billion in 2023 and is anticipated to reach around USD 19.65 billion by 2033, growing at a CAGR of 14.9% from 2024 to 2033.
The rising prevalence of chronic diseases, increased investments in research and development, and a growing number of clinical trials for cell-based therapies are driving the market growth. Additionally, growing collaborations and partnerships among market players are expected to further contribute to the market growth.
The market has had a positive impact during the pandemic. This is attributed to the increased demand for research and development in diagnostics, therapeutics, and vaccine development. The urgency of these needs accelerated the adoption and innovation of cell culture technologies. The increased focus on rapid development and testing of treatments and vaccines emphasized the demand for cell culture vessels in addressing global health challenges. Thereby anticipated to significantly raise the growth of the market during the pandemic.
Furthermore, the rising incidence of chronic diseases such as cancer and diabetes significantly impacts the cell culture vessel market. This growing demand for research drives the need for specialized cell culture vessels that can support various types of cell lines and experimental conditions, ensuring accurate and reliable results. In September 2023, the Novo Nordisk Foundation invested around USD 141.29 million (€ 127 million) to build a top facility for developing and scaling cell therapies, aiming to turn research into treatments for diseases such as heart failure, Parkinson's, and cancer. Thus, the growing investment and increasing prevalence of chronic diseases is anticipated to propel the demand for cell culture vessels over the forecast period.
Moreover, the market for cell culture vessels is expected to experience significant growth in the coming years, driven by the increasing demand for personalized medicine. Advancements in personalized medicine, particularly in precision oncology, have increased the need for patient-derived cell models and cultures. Researchers are now able to use primary cells or organoids derived from patients to study disease mechanisms or test potential treatments. Thereby, the demand for cell culture vessels is predicted to grow exponentially with the increasing adoption of personalized medicine, creating significant opportunities for businesses operating in this market over the forecast period.
| Report Attribute | Details |
| Market Size in 2024 | USD 5.63 Billion |
| Market Size by 2033 | USD 19.65 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 14.9% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product, type, end use, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; STEMCELL Technologies; Merck KGaA; Greiner Bio-One International GmbH; Corning Incorporated; Wilson Wolf; DWK Life Sciences; Cell Culture Company, LLC; VWR International, LLC.; Danaher, Sartorius Stedim Biotech |
Based on product, the market is segmented into bags, flasks, plates, bottles, and others. The bags segment dominated the market with a share of 39.81% in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2033. This is attributed to the growing preference for flexible, single use bags in cell culture applications due to their ease of use, reduced risk of contamination, and cost-effectiveness. Bags are increasingly favored for their suitability in operating a range of applications, from research to large-scale production. For instance, in March 2024, Getinge announced the launch of a novel SUPR system, a scalable single use bioreactor for pilot and GMP manufacturing. It features larger versions of their lab-scale bioreactors, comes sterilized by gamma irradiation, and is more space-efficient. It also includes easy-to-use click-n-go bag loading. Such launches are further anticipated to boost the growth of the segment over the forecast period.
The flasks segment is expected to register significant CAGR over the forecast period. Flasks are widely used in laboratories for various applications, including cell growth, maintenance, and experimentation due to their ability to support different types of cell cultures and their compatibility with various laboratory processes. Thus, increasing R&D activities is anticipated to boost the demand for flasks over the forecast years.
Based on type, the market is segmented into reusable and single use. The single use segment dominated the market with a share of 70.98% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. This is attributed to the increasing adoption of single use technologies in research and production environments, which offer significant advantages such as reduced risk of contamination, lower operational costs. In August 2024, Freudenberg Medical announced the expansion of its biopharma products to include custom single use assemblies, such as Y-connector manifolds, tubing assemblies, and multi-inlet bottle caps. These would be used in labs and CGMP bioprocesses for critical fluid transfers. Thus, anticipated to boost the growth of the segment over the forecast period.
The reusable segment is expected to register a moderate CAGR over the forecast period. This is attributed to the advantages of reusable cell culture vessels, such as their durability and long-term cost efficiency, thereby making them a better option for large-scale and high-volume applications.
Based on end use, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and CMOs & CROs. The pharmaceutical & biotechnology companies segment dominated the market with a share of 47.09% in 2023. This is attributed to the extensive use of cell culture vessels for drug discovery, development, and production. Moreover, the high investment in R&D, coupled with the increasing focus on advanced therapies and personalized medicine, is further driving the demand for cell culture vessels significantly.
The CMOs & CROs segment is expected to register the highest CAGR over the forecast period. The rising outsourcing of research and manufacturing by pharmaceutical and biotechnology companies is anticipated to drive segmental growth over the forecast period. Furthermore, the provision of services such as drug discovery, preclinical and clinical trials, and manufacturing of cell-based therapies is contributing to the demand for cell culture vessels by CMOs & CROs.
North America accounted for the largest market share of 40.19% in 2023 for the cell culture vessel market. This significant share is driven by a combination of factors, including a robust biopharmaceutical industry, high investments in research and development, and advanced healthcare infrastructure. The region's leadership in innovation and technological advancements, along with a rising incidence of chronic diseases and a supportive regulatory environment, further fuels the demand for cell culture vessels.
U.S. Cell Culture Vessels Market Trends
The cell culture vessels market in the U.S. is expected to grow over the forecast period. In July 2023, MilliporeSigma announced an investment of USD 25 million to expand its cell culture media production in Kansas, U.S.
Europe Cell Culture Vessels Market Trends
Europe cell culture vessels market was identified as a lucrative region in this industry. This growth is driven by a robust biotechnology and pharmaceutical sector. New companies and startups are emerging, and increased collaboration among research institutions is expected to further boost the market.
The cell culture vessels market in the UK held a significant share in 2023. This is attributed to the advanced research facilities, strong pharmaceutical and biotechnology sectors, and high investment in healthcare innovation. Additionally, the increasing focus on cutting-edge cell culture technologies, extensive clinical research, and the supportive regulatory environment are further contributing to the growing market growth.
France cell culture vessels market is expected to grow significantly over the forecast period. The increasing funding for healthcare research, the expansion of clinical trials, and a growing emphasis on personalized medicine are contributing to the market's expansions.
The cell culture vessels market in Germany is anticipated to grow significantly over the forecast period. In April 2024, Merck announced an investment of over USD 333.76 million (€300 million) in a new Life Science Research Center in Germany, which will consolidate research on key technologies to accelerate the development of biopharmaceutical products. Thereby propelling the demand for cell culture vessels over the forecast period.
Asia Pacific Cell Culture Vessels Market Trends
The Asia Pacific cell culture vessels market held highest CAGR of 17.84% over the forecast period. This is attributed to several factors, including increasing investments in biotechnology & pharmaceutical research, a rise in the prevalence of chronic diseases, advancements in healthcare infrastructure, and growing demand for regenerative medicine and personalized therapies. Additionally, supportive government initiatives and an expanding base of research institutions and biopharmaceutical companies in the region are further driving market growth.
The cell culture vessels market in China is expected to grow over the forecast period. This is attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, which is expected to elevate the demand for various drugs. Thereby, increasing the demand for cell culture vessels for research, clinical applications, and drug development, thus, propelling the market growth over the forecast period.
Japan cell culture vessels market is witnessing rapid growth over the forecast period. The presence of numerous pharmaceutical & biotechnology companies, increasing health consciousness, and a growing demand for preventive healthcare are expected to boost the demand for cell culture vessels for various research activities and clinical purposes.
MEA Cell Culture Vessels Market Trends
The MEA cell culture vessels marketis expected to grow exponentially over the forecast period due to several key factors. These include increased investments in healthcare infrastructure and research, a rise in chronic diseases, widespread use of advanced diagnostic technologies, government initiatives to improve healthcare standards, and the growth of international partnerships and collaborations.
Saudi Arabia cell culture vessels market is expected to grow over the forecast period. This growth is expected to be driven by increasing collaborations between research and academic institutions for biotechnology-related research.
The cell culture vessels market in Kuwait is anticipated to grow moderately over the forecast period. This is attributed to rising healthcare expenditure aimed at improving healthcare infrastructure services, and the adoption of new technologies.
The following are the leading companies in the cell culture vessels market. These companies collectively hold the largest market share and dictate industry trends.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Cell Culture Vessels market.
By Product
By Type
By End Use
By Region
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Type Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing research and development activities
3.2.1.2. Rising incidence of chronic diseases
3.2.1.3. Advancements in cell therapy and regenerative medicine
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced cell culture vessels
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Cell Culture Vessels Market: Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Cell Culture Vessels Market Product Movement Analysis
4.3. Global Cell Culture Vessels Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Bags
4.4.1. Global Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Flasks
4.5.1. Global Flasks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. T-flasks
4.5.2.1. Global T-flasks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Spinner Flasks
4.5.3.1. Global Spinner Flasks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Gas Permeable Membrane Flasks
4.5.4.1. Global Gas Permeable Membrane Flasks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Others
4.5.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Plates
4.6.1. Global Plates Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Bottles
4.7.1. Global Bottles Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Others
4.8.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Cell Culture Vessels Market: Type Business Analysis
5.1. Type Segment Dashboard
5.2. Global Cell Culture Vessels Market Type, Movement Analysis
5.3. Global Cell Culture Vessels Market Size & Trend Analysis, by Type, 2021 - 2033 (USD Million)
5.4. Reusable
5.4.1. Global Reusable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Single use
5.5.1. Global Single use Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Cell Culture Vessels Market: End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Global Cell Culture Vessels Market End Use Movement Analysis
6.3. Global Cell Culture Vessels Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. CMOs & CROs
6.6.1. Global CMOs & CROs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Cell Culture Vessels Market: Regional Estimates & Trend Analysis by Product, Type, and End Use
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 - 2033
7.3. North America
7.3.1. North America Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Europe Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. MEA
7.7.1. MEA Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait Cell Culture Vessels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Participant’s Overview
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. STEMCELL Technologies
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Greiner Bio-One International GmbH
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Corning Incorporated
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Wilson Wolf
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. DWK Life Sciences
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Cell Culture Company, LLC
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. VWR International, LLC.
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Danaher
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Sartorius Stedim Biotech
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers